Zosano Pharma, Inc. Announces Publication Of Positive Phase 2 Study Of Its ZP-PTH Patch For Osteoporosis Therapy
Links shared publicly online about this topic.
- 1,610total visits
Zosano Pharma, Inc. Announces Publication Of Positive Phase 2 Study Of Its ZP-PTH Patch For Osteoporosis Therapy
View full resource at medicalnewstoday.com
Tags: Osteoporosis, Pharma, Phase 2 Clinical Trial
Most Recently Shared on November 11, 2009 at 1:14 pm By:
Zosano Pharma, Inc. Announces Publication Of Positive Phase 2 Study Of Its ZP-PTH Patch For Osteoporosis Therap.. http://bit.ly/2SvWWj
Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis
news-medical.net — “Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.” View full resource at news-medical.net
Most Recently Shared on November 9, 2009 at 5:25 pm By:
Osteoporosis News: Positive study data from Zosano Pharma's ZP-PTH transdermal patch for trea.. http://bit.ly/2y5a3L
Advertisement
